Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Utilizing genome-scale models to optimize nutrient supply for sustained algal growth and lipid productivity.

Li CT, Yelsky J, Chen Y, Zuñiga C, Eng R, Jiang L, Shapiro A, Huang KW, Zengler K, Betenbaugh MJ.

NPJ Syst Biol Appl. 2019 Sep 24;5:33. doi: 10.1038/s41540-019-0110-7. eCollection 2019.

2.

Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC.

Yoon S, Huang KW, Andrikakou P, Vasconcelos D, Swiderski P, Reebye V, Sodergren M, Habib N, Rossi JJ.

Mol Ther Nucleic Acids. 2019 Aug 22;18:142-154. doi: 10.1016/j.omtn.2019.08.017. [Epub ahead of print]

4.

Graptopetalum paraguayense Inhibits Liver Fibrosis by Blocking TGF-β Signaling In Vivo and In Vitro.

Hsu WH, Liao SC, Chyan YJ, Huang KW, Hsu SL, Chen YC, Siu ML, Chang CC, Chung YS, Huang CF.

Int J Mol Sci. 2019 May 27;20(10). pii: E2592. doi: 10.3390/ijms20102592.

5.

Positive Immuno-Modulation Following Radiofrequency Assisted Liver Resection in Hepatocellular Carcinoma.

Huang KW, Jayant K, Lee PH, Yang PC, Hsiao CY, Habib N, Sodergren MH.

J Clin Med. 2019 Mar 19;8(3). pii: E385. doi: 10.3390/jcm8030385.

6.

Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized Mice.

Zhou J, Li H, Xia X, Herrera A, Pollock N, Reebye V, Sodergren MH, Dorman S, Littman BH, Doogan D, Huang KW, Habib R, Blakey D, Habib NA, Rossi JJ.

Mol Ther. 2019 May 8;27(5):999-1016. doi: 10.1016/j.ymthe.2019.02.018. Epub 2019 Feb 26.

7.

A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from the AHPBA pancreatic registry.

Holland MM, Bhutiani N, Kruse EJ, Weiss MJ, Christein JD, White RR, Huang KW, Martin RCG 2nd.

HPB (Oxford). 2019 Aug;21(8):1024-1031. doi: 10.1016/j.hpb.2018.12.004. Epub 2019 Feb 5.

PMID:
30737097
8.

Mechanisms involved in the activation of C/EBPα by small activating RNA in hepatocellular carcinoma.

Zhao X, Reebye V, Hitchen P, Fan J, Jiang H, Sætrom P, Rossi J, Habib NA, Huang KW.

Oncogene. 2019 May;38(18):3446-3457. doi: 10.1038/s41388-018-0665-6. Epub 2019 Jan 14.

PMID:
30643190
9.

A Systematic Review and Meta-Analysis Comparing Liver Resection with the Rf-Based Device Habib™-4X with the Clamp-Crush Technique.

Jayant K, Sodergren MH, Reccia I, Kusano T, Zacharoulis D, Spalding D, Pai M, Jiao LR, Huang KW.

Cancers (Basel). 2018 Nov 8;10(11). pii: E428. doi: 10.3390/cancers10110428. Review.

10.

Irreversible Electroporation: A Novel Ultrasound-guided Modality for Non-thermal Tumor Ablation.

Hsiao CY, Huang KW.

J Med Ultrasound. 2017 Oct-Dec;25(4):195-200. doi: 10.1016/j.jmu.2017.08.003. Epub 2017 Oct 6. Review.

11.

Validation of Assaying Carcinoembryonic Antigen in Human Serum by Using Immunomagnetic Reduction.

Wei PL, Lee LT, Tseng LM, Huang KW.

Sci Rep. 2018 Jul 3;8(1):10002. doi: 10.1038/s41598-018-28215-1.

12.

Comparison of Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma in the Caudate Lobe.

Lee BC, Liu KL, Wu CH, Huang KW, Ho CM, Hu RH, Ho MC, Wu YM, Lee PH, Liang PC.

Cardiovasc Intervent Radiol. 2018 Nov;41(11):1699-1707. doi: 10.1007/s00270-018-1978-0. Epub 2018 Jun 26.

PMID:
29946941
13.

The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma.

Huang KW, Yang PC, Pua U, Kim MD, Li SP, Qiu YD, Song TQ, Liang PC.

J Surg Oncol. 2018 Jul;118(1):31-36. doi: 10.1002/jso.25110. Epub 2018 Jun 7.

PMID:
29878378
14.

Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy.

Su TH, Liao CH, Liu CH, Huang KW, Tseng TC, Yang HC, Liu CJ, Chen PJ, Chen DS, Kao JH.

Radiology. 2018 Jul;288(1):293-299. doi: 10.1148/radiol.2018171116. Epub 2018 Mar 27.

PMID:
29584594
15.

Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer.

Reebye V, Huang KW, Lin V, Jarvis S, Cutilas P, Dorman S, Ciriello S, Andrikakou P, Voutila J, Saetrom P, Mintz PJ, Reccia I, Rossi JJ, Huber H, Habib R, Kostomitsopoulos N, Blakey DC, Habib NA.

Oncogene. 2018 Jun;37(24):3216-3228. doi: 10.1038/s41388-018-0126-2. Epub 2018 Mar 7.

16.

Impact of cavitron ultrasonic surgical aspirator (CUSA) and bipolar radiofrequency device (Habib-4X) based hepatectomy for hepatocellular carcinoma on tumour recurrence and disease-free survival.

Huang KW, Lee PH, Kusano T, Reccia I, Jayant K, Habib N.

Oncotarget. 2017 Sep 26;8(55):93644-93654. doi: 10.18632/oncotarget.21271. eCollection 2017 Nov 7.

17.

A novel photodynamic therapy-based drug delivery system layered on a stent for treating cholangiocarcinoma.

Liang PC, Huang KW, Tung CC, Chang MC, Chang FY, Wong JM, Chang YT.

Biomed Microdevices. 2017 Nov 22;20(1):3. doi: 10.1007/s10544-017-0249-1.

PMID:
29164403
18.

Characterizations of Anti-Alpha-Fetoprotein-Conjugated Magnetic Nanoparticles Associated with Alpha-Fetoprotein for Biomedical Applications.

Liao SH, Huang HS, Chieh JJ, Su YK, Tong YF, Huang KW.

Sensors (Basel). 2017 Sep 3;17(9). pii: E2018. doi: 10.3390/s17092018.

19.

Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis.

Su TH, Shiau CW, Jao P, Yang NJ, Tai WT, Liu CJ, Tseng TC, Yang HC, Liu CH, Huang KW, Hu TC, Huang YJ, Wu YM, Chen LJ, Chen PJ, Chen DS, Chen KF, Kao JH.

Sci Rep. 2017 May 11;7(1):1728. doi: 10.1038/s41598-017-01572-z.

20.

Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell Growth.

Yoon S, Huang KW, Reebye V, Spalding D, Przytycka TM, Wang Y, Swiderski P, Li L, Armstrong B, Reccia I, Zacharoulis D, Dimas K, Kusano T, Shively J, Habib N, Rossi JJ.

Mol Ther Nucleic Acids. 2017 Mar 17;6:80-88. doi: 10.1016/j.omtn.2016.11.008. Epub 2016 Dec 10.

Supplemental Content

Loading ...
Support Center